149 related articles for article (PubMed ID: 15825631)
1. Drug utilization: using objective data to achieve cost-efficiency.
Eber BL
Benefits Q; 2005; 21(1):7-13. PubMed ID: 15825631
[TBL] [Abstract][Full Text] [Related]
2. Seeking value in working with pharmacy benefit managers.
Vogenberg FR; Sica JM
Benefits Q; 2003; 19(1):7-12. PubMed ID: 12608113
[TBL] [Abstract][Full Text] [Related]
3. Developing an effective generic prescription drug program.
Jones JD
Benefits Q; 2003; 19(1):14-8. PubMed ID: 12608114
[TBL] [Abstract][Full Text] [Related]
4. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
5. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
Kirking DM; Ascione FJ; Richards JW
Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
[TBL] [Abstract][Full Text] [Related]
6. A successful field-based pharmacy program.
Miller W
Med Interface; 1995 Feb; 8(2):71-4, 77. PubMed ID: 10140634
[TBL] [Abstract][Full Text] [Related]
7. Rebates and spreads: pharmacy benefit management practices and corporate citizenship.
Rentmeester CA; Garis RI
J Health Polit Policy Law; 2008 Oct; 33(5):943-63; discussion 965-978. PubMed ID: 18818428
[TBL] [Abstract][Full Text] [Related]
8. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
Sullivan PW; Nair KV; Patel BV
Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
[TBL] [Abstract][Full Text] [Related]
9. The evolving pharmacy benefit market.
Navarro RP
Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345
[TBL] [Abstract][Full Text] [Related]
10. Prescription drug benefit design: the building blocks and their impact on cost.
Kopenski F
Benefits Q; 2008; 24(4):7-11. PubMed ID: 19048742
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the ramifications of recent pharmaceutical industry acquisitions by looking at the past, present and future of PBMs (pharmacy benefit management firms).
Herzfeld JD
Empl Benefits J; 1995 Mar; 20(1):20-3, 30. PubMed ID: 10142515
[No Abstract] [Full Text] [Related]
12. What employers can do about pharmaceutical costs.
Norton JA
J Health Care Benefits; 1994; 4(1):4-8. PubMed ID: 10137544
[TBL] [Abstract][Full Text] [Related]
13. Unlock savings through innovative pharmacy benefit design.
Edlin M
AHIP Cover; 2005; 46(4):14-20. PubMed ID: 16149655
[No Abstract] [Full Text] [Related]
14. Supply and demand: negotiating the prescription drug labyrinth to reduce costs.
DeStefino K
Benefits Q; 2003; 19(1):30-7. PubMed ID: 12608116
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy quality improvement: use of a clinical rule-based application.
Kolb KW
Pharm Pract Manag Q; 1996 Oct; 16(3):1-10. PubMed ID: 10166230
[TBL] [Abstract][Full Text] [Related]
16. Prescription drug utilization review in the private sector.
Kralewski J; Wertheimer A; Ratner E
Health Care Manage Rev; 1994; 19(2):62-71. PubMed ID: 8089024
[TBL] [Abstract][Full Text] [Related]
17. Trends in prescription drug expenditures by Medicaid enrollees.
Banthin JS; Miller GE
Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
[TBL] [Abstract][Full Text] [Related]
18. Prescription drug benefits: promising solutions.
Goff VV
Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
[TBL] [Abstract][Full Text] [Related]
19. Strategies for acquiring affordable medications for seniors.
Morris KJ
Nurs Clin North Am; 2005 Mar; 40(1):51-62, vi. PubMed ID: 15733946
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals in Australia: priorities in a teaching hospital.
Kearney BJ
Physician Exec; 1993; 19(5):63-7. PubMed ID: 10130953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
